Anti-Human HLA-DR Antibody [L243]
Anti-Human HLA-DR Antibody [L243] with collaborator-tested evidence for Flow Cyt. Read more ›
["FCM"]Product Description
HLA-DR is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Mouse; clonality: Monoclonal; clone: L243; isotype: Mouse IgG2a, κ; available conjugation options: None (AF/LE), Unconjugated, Biotin, FITC, PE, APC, PerCP, PE/Cyanine 5, PE/Cyanine 7, PE/Cyanine 5.5, PerCP/Cyanine 5.5, Elab Fluor®700, Elab Fluor®Violet 450, Elab Fluor®Violet 500, Elab Fluor®Red 780, Elab Fluor®Violet 610, Elab Fluor®Violet 540.
Application evidence: Elabscience lists this product for FCM. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human HLA-DR protein; purification: >98%, Protein A/G purified; concentration: ≥ 1 mg/mL.
Database references: UniProt: P01903;P01911; | NCBI Gene: 3122;3123.
Research Use Only.
Key Facts
| Target | HLA-DR |
| Also known as | DRA/DRB1, HLA class II histocompatibility antigen DR alpha/ DRB1-15 beta chain, HLA-DRA1/DRB1, MHC class II antigen DRA |
| Concentration | ≥ 1 mg/mL |
| Species reactivity | Human |
| Purity | >98% |
| Shelf life | 12 months from shipping dates |
| Research area | Immunology, Innate Immunity |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.